Onward Medical N.V. 63E.F · Stock Open Onward Medical N.V. in new tab
Onward Medical N.V. Analysis (63E.F)
Is Onward Medical N.V. a good investment? Onward Medical N.V. (63E.F) is currently trading at 2.45 EUR.
Investor FAQ
Does Onward Medical N.V. pay a dividend?
No, it does not currently pay a dividend.
What asset class is Onward Medical N.V.?
Onward Medical N.V. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
Company Profile
Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with spinal cord injury (SCI) in the United States, Europe, and internationally. The company offers ARCEX System, an external stimulator that is intended to improve hand strength and sensation following SCI; ARCIM System, an implantable system currently used to explore potential indications in clinical feasibility studies; ARCBCI System, an implantable system currently being investigated to enable thought driven movement of the legs and upper extremities. Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands.
Community Discussion